Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Phospholipids Syndrome (APS)”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableNot Yet RecruitingNCT06884384
What this trial is testing

DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study

Who this might be right for
Antiphospholipid Syndrome (APS)Cohort StudyThrombotic and Bleeding Events
Central Hospital, Nancy, France 310
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Testing effectiveness (Phase 2)WithdrawnNCT00180778
What this trial is testing

Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss

Who this might be right for
Antiphospholipid Syndrome
Imperial College London
Not applicableStudy completedNCT05195372
What this trial is testing

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeVenous ThromboembolismArterial Thromboembolism+1 more
Cardioangiologisches Centrum Bethanien 80
Post-approval studies (Phase 4)Looking for participantsNCT05995600
What this trial is testing

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

Who this might be right for
Antiphospholipid SyndromeIschemic StrokeTransient Ischemic Attack+3 more
Seoul National University Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT02128269
What this trial is testing

Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid (aPL)-Positive
Alexion Pharmaceuticals, Inc. 9
Not applicableLooking for participantsNCT05646394
What this trial is testing

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Who this might be right for
Antiphospholipid SyndromeArterial Thrombosis
McMaster University 150
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Early research (Phase 1)Not Yet RecruitingNCT07123519
What this trial is testing

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Post-approval studies (Phase 4)Study completedNCT02326051
What this trial is testing

Timing of Initiation of LMWH Administration in Pregnant Women With APS

Who this might be right for
Recurrent MiscarriageAntiphospholipid Syndrome
Mohamed Sayed Abdelhafez 100
Not applicableUnknownNCT05644210
What this trial is testing

Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

Who this might be right for
Antiphospholipid Syndrome
Qilu Hospital of Shandong University 80
Not applicableActive Not RecruitingNCT01787305
What this trial is testing

Pilot Study of Gut Commensals in Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome (APS)
Yale University 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07172022
What this trial is testing

Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)

Who this might be right for
Antiphospholipid Syndrome
Hoffmann-La Roche 300
Early research (Phase 1)WithdrawnNCT00278616
What this trial is testing

Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome

Who this might be right for
ANTIPHOSPHOLIPID SYNDROME
Richard Burt, MD
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06504420
What this trial is testing

The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study

Who this might be right for
Primary Antiphospholipid Syndrome
Peking University People's Hospital 70
Not applicableLooking for participantsNCT00616317
What this trial is testing

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Who this might be right for
Antiphospholipid Syndrome
University of California, Davis 50
Not applicableLooking for participantsNCT07178925
What this trial is testing

Follow-up Cohort of Patients With Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome (APS)
University Hospital, Rouen 200
Testing effectiveness (Phase 2)Study completedNCT02595346
What this trial is testing

Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome (APS)
University Hospital, Rouen 25
Not applicableLooking for participantsNCT04262492
What this trial is testing

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

Who this might be right for
Antiphospholipid SyndromeThrombosisAnticoagulants Causing Adverse Effects in Therapeutic Use
Stéphane Zuily 500
Early research (Phase 1)Enrolling By InvitationNCT06723106
What this trial is testing

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Load More Results